Insider Transactions in Q4 2021 at Heron Therapeutics, Inc. (HRTX)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 22
2021
|
Stephen Davis Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,452
+43.72%
|
-
|
|
Dec 22
2021
|
Sharmila Dissanaike Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,452
+38.49%
|
-
|
|
Dec 22
2021
|
Susan Rodriguez Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,452
+38.49%
|
-
|
|
Dec 22
2021
|
Craig A Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,452
+44.02%
|
-
|
|
Dec 22
2021
|
Waage Christian Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,452
+43.36%
|
-
|
|
Dec 21
2021
|
Craig A Johnson Director |
SELL
Open market or private sale
|
Direct |
250
-8.09%
|
$2,250
$9.73 P/Share
|
|
Dec 21
2021
|
Waage Christian Director |
SELL
Open market or private sale
|
Direct |
300
-8.57%
|
$2,700
$9.73 P/Share
|
|
Oct 29
2021
|
John Poyhonen President & CCO |
BUY
Other acquisition or disposition
|
Direct |
817
+3.31%
|
$7,353
$9.36 P/Share
|
|
Oct 13
2021
|
Kimberly Manhard EVP, Drug Development |
SELL
Payment of exercise price or tax liability
|
Direct |
433
-11.7%
|
$4,330
$10.55 P/Share
|
|
Oct 13
2021
|
Kimberly Manhard EVP, Drug Development |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+25.25%
|
-
|
|
Oct 13
2021
|
Lisa Peraza VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
191
-1.33%
|
$1,910
$10.55 P/Share
|
|
Oct 13
2021
|
Lisa Peraza VP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
552
+3.69%
|
-
|
|
Oct 13
2021
|
John Poyhonen President & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
433
-1.85%
|
$4,330
$10.55 P/Share
|
|
Oct 13
2021
|
John Poyhonen President & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+5.06%
|
-
|
|
Oct 13
2021
|
Barry D Quart Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
963
-0.93%
|
$9,630
$10.55 P/Share
|
|
Oct 13
2021
|
Barry D Quart Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,646
+3.42%
|
-
|
|
Oct 13
2021
|
David Leslie Szekeres EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
433
-9.81%
|
$4,330
$10.55 P/Share
|
|
Oct 13
2021
|
David Leslie Szekeres EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+22.07%
|
-
|